Cargando…
The challenge of targeting metastasis
Metastases that are resistant to conventional therapy are the major cause of death from cancer. In most patients, metastasis has already occurred by the time of diagnosis. Thus, the prevention of metastasis is unlikely to be of therapeutic benefit. The biological heterogeneity of metastases presents...
Autores principales: | Fidler, Isaiah J., Kripke, Margaret L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661188/ https://www.ncbi.nlm.nih.gov/pubmed/26328524 http://dx.doi.org/10.1007/s10555-015-9586-9 |
Ejemplares similares
-
Cell–cell and cell–matrix dynamics in intraperitoneal cancer metastasis
por: Sodek, Katharine L., et al.
Publicado: (2012) -
EPLIN: a fundamental actin regulator in cancer metastasis?
por: Collins, Ross J., et al.
Publicado: (2015) -
Molecular mediators of peritoneal metastasis in pancreatic cancer
por: Avula, Leela Rani, et al.
Publicado: (2020) -
Nanotechnology-aided advancement in the combating of cancer metastasis
por: Avula, Leela Rani, et al.
Publicado: (2022) -
The non-coding transcriptome as a dynamic regulator of cancer metastasis
por: Crea, Francesco, et al.
Publicado: (2013)